Blue Trust Inc’s Cardlytics CDLX Stock Holding History

Blue Trust Inc’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-83	Closed	-$6.84K	–	2522
2024 Q3	$6.84K	Buy	83 +45	+118%	+$2.5K	﹤0.01%	2317
2024 Q2	$5.56K	Buy	+38	New	+$4.11K	﹤0.01%	2159
2023 Q3	–	Sell	-3	Closed	–	–	2063
2023 Q2	$0	Sell	3 -1	-25%	-$61	﹤0.01%	2072
2023 Q1	$0	Sell	4 -10	-71%	-$522	﹤0.01%	2333
2022 Q4	$2K	Buy	14 +11	+367%	+$680	﹤0.01%	1903
2022 Q3	$1K	Buy	+3	New	+$427	﹤0.01%	1890

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blue Trust Inc's CDLX Position: Q4 2024 in Review

Blue Trust Inc sold out of Cardlytics (CDLX) in Q4 2024, closing a stake of 83 shares — an estimated $6.84K sold.

Blue Trust Inc first reported a position in CDLX in Q3 2022 and held it in 6 quarters. The position peaked at $6.84K in Q3 2024. 108 funds tracked by Wall St. Rank hold CDLX as of Q4 2024.

Blue Trust Inc reported no remaining Cardlytics position as of Q4 2024 after selling out during the quarter.
Blue Trust Inc sold 83 Cardlytics shares in Q4 2024, an estimated $6.84K.
Blue Trust Inc first reported a position in Cardlytics in Q3 2022 and held it in 6 quarters.
Blue Trust Inc's Cardlytics position peaked at $6.84K in Q3 2024.
108 funds tracked by Wall St. Rank held Cardlytics as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.